6-(5-fluoropyridin-3-yloxy)-N-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-8-carboxamide

ID: ALA4088174

PubChem CID: 118103886

Max Phase: Preclinical

Molecular Formula: C19H14FN5O2

Molecular Weight: 363.35

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(NC(=O)c2cc(Oc3cncc(F)c3)cn3ccnc23)n1

Standard InChI:  InChI=1S/C19H14FN5O2/c1-12-3-2-4-17(23-12)24-19(26)16-8-15(11-25-6-5-22-18(16)25)27-14-7-13(20)9-21-10-14/h2-11H,1H3,(H,23,24,26)

Standard InChI Key:  YBOSMXKKLRKHMB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.3045  -13.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7211  -14.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7182  -13.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0096  -12.9881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0114  -14.6254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3036  -14.2195    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6988  -14.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0328  -15.5117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440  -15.4240    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0072  -12.1709    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7136  -11.7602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4205  -12.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1265  -11.7590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1245  -10.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4106  -10.5347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7075  -10.9470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4052   -9.7175    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4294  -14.6235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4307  -15.4407    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1365  -14.2138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8448  -14.6213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8415  -15.4369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5490  -15.8443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2570  -15.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2531  -14.6131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5450  -14.2094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9587  -14.2009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  1  0
  5  2  1  0
  2  3  2  0
  3  4  1  0
  4  1  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
  2 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
M  END

Associated Targets(Human)

Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grm5 Metabotropic glutamate receptor 5 (4372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.35Molecular Weight (Monoisotopic): 363.1132AlogP: 3.62#Rotatable Bonds: 4
Polar Surface Area: 81.41Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.90CX Basic pKa: 5.38CX LogP: 1.78CX LogD: 1.78
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -2.00

References

1. Felts AS, Rodriguez AL, Morrison RD, Bollinger KA, Venable DF, Blobaum AL, Byers FW, Thompson Gray A, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA..  (2017)  Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.,  27  (21): [PMID:28958625] [10.1016/j.bmcl.2017.09.042]

Source